Cutting edge: predetermined avidity of human CD8 T cells expanded on calibrated MHC/anti-CD28-coated microspheres.

Cytotoxic CD8 T cells are key effectors in the immunotherapy of malignant and viral diseases. However, the lack of efficient methods for their in vitro priming and expansion has become a bottleneck to the development of vaccines and adoptive transfer strategies. Synthetic artificial APCs (aAPCs) are now emerging as an attractive tool for eliciting and expanding CTL responses. We show that, by controlling the MHC density on aAPCs, high- or low-avidity tumor-directed human CTL lines can be raised effectively in vitro if costimulation via CD28 and IL-12 is provided. Compared with low-avidity CTL lines, high-avidity CTLs need 100- to 1000-fold less peptide for activation, bind more MHC tetramers, and, as expected, are superior in recognizing tumor cell lines expressing Ag. We believe that the possibility to raise Ag-specific T cells with predetermined avidity will be crucial for the future use of aAPCs in immunotherapeutical settings.
AuthorsSteffen Walter, Leah Herrgen, Oliver Schoor, Gundram Jung, Dorothee Wernet, Hans-Jörg Bühring, Hans-Georg Rammensee, Stefan Stevanović
JournalJournal of immunology (Baltimore, Md. : 1950) (J Immunol) Vol. 171 Issue 10 Pg. 4974-8 (Nov 15 2003) ISSN: 0022-1767 [Print] United States
PMID14607891 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antigens, CD28
  • HLA-A Antigens
  • HLA-A*02:01 antigen
  • HLA-A2 Antigen
  • Immune Sera
  • Interleukin-12
  • Biotin
  • Streptavidin
  • Antigen-Presenting Cells (immunology)
  • Antigens, CD28 (immunology)
  • Biotin (metabolism)
  • CD8-Positive T-Lymphocytes (cytology, immunology, metabolism)
  • Calibration (standards)
  • Cell Adhesion (immunology)
  • Cell Division (immunology)
  • Cells, Cultured
  • Cytotoxicity Tests, Immunologic (methods, standards)
  • Dose-Response Relationship, Immunologic
  • HLA-A Antigens (metabolism)
  • HLA-A2 Antigen
  • Humans
  • Immune Sera (metabolism)
  • Interleukin-12 (pharmacology)
  • Lymphocyte Activation (immunology)
  • Microspheres
  • Streptavidin (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: